1.
Transpl Int
; 30(8): 765-775, 2017 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28543878
RESUMO
This article provides a transparent description of Mreg_UKR cell products, including manufacture and quality-control processes, using the structure and vocabulary of the 'Minimum Information about Tolerogenic Antigen-presenting Cells' reporting guidelines. This information is intended as a resource for those in the field, as well as a stimulus to develop a new wave of immunoregulatory and tissue-reparative monocyte-derived cell therapies.